UK health cost body backs Novartis asthma drug in fresh U-turn
Britain’s healthcost-effectivness watchdog NICE said it planned to recommend theuse of Novartis’s severe asthma drug Xolair afterprevaricating for months over whether it should be paid for onthe taxpayer-funded …
Categories: Uncategorized Tags: for-months, nice, novartis, onthe-taxpayer-funded, over-whether, paid-for, recommend-theuse, said-it-planned, severe-asthma, taxpayer, whether-it-should, xolair